Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
To identify patterns of zidovudine ( AZT ) susceptibility among mother/infant pairs with perinatal HIV transmission.
Most HIV-infected infants acquire their disease via perinatal transmission. Since transmission of HIV-resistant strains to infants could alter the course of disease and response to currently recommended treatment, a study to assess the patterns of AZT susceptibility among mother/infant pairs with perinatal transmission is essential to delineate future therapeutic strategies.
研究概览
详细说明
Most HIV-infected infants acquire their disease via perinatal transmission. Since transmission of HIV-resistant strains to infants could alter the course of disease and response to currently recommended treatment, a study to assess the patterns of AZT susceptibility among mother/infant pairs with perinatal transmission is essential to delineate future therapeutic strategies.
HIV-infected pregnant women are enrolled at 20-36 weeks gestation. Patients have blood drawn for HIV culture at study entry and at delivery. Infants have blood drawn for HIV culture at delivery and at 1, 3, 6, and 18 months of age.
研究类型
注册
联系人和位置
学习地点
-
-
-
San Juan、波多黎各、009367344
- San Juan City Hosp
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35294
- Univ of Alabama at Birmingham Schl of Med / Pediatrics
-
-
California
-
La Jolla、California、美国、920930672
- UCSD Med Ctr / Pediatrics / Clinical Sciences
-
Long Beach、California、美国、90801
- Long Beach Memorial (Pediatric)
-
Los Angeles、California、美国、90033
- Los Angeles County - USC Med Ctr
-
Los Angeles、California、美国、905022004
- Harbor - UCLA Med Ctr / UCLA School of Medicine
-
Los Angeles、California、美国、900951752
- UCLA Med Ctr / Pediatric
-
-
Connecticut
-
Farmington、Connecticut、美国、06032
- Univ of Connecticut / Farmington
-
Hartford、Connecticut、美国、06106
- Connecticut Children's Med Ctr - Pediatric
-
-
District of Columbia
-
Washington、District of Columbia、美国、200102916
- Children's Hosp of Washington DC
-
Washington、District of Columbia、美国、20060
- Howard Univ Hosp
-
-
Florida
-
Miami、Florida、美国、33161
- Univ of Miami (Pediatric)
-
-
Illinois
-
Chicago、Illinois、美国、606371470
- Univ of Chicago Children's Hosp
-
-
Louisiana
-
New Orleans、Louisiana、美国、701122699
- Tulane Univ / Charity Hosp of New Orleans
-
New Orleans、Louisiana、美国、70112
- Univ Hosp
-
-
Maryland
-
Baltimore、Maryland、美国、212874933
- Johns Hopkins Hosp - Pediatric
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- Brigham and Women's Hosp
-
Boston、Massachusetts、美国、021155724
- Children's Hosp of Boston
-
Springfield、Massachusetts、美国、01199
- Baystate Med Ctr of Springfield
-
-
New Jersey
-
Newark、New Jersey、美国、071032714
- Univ of Medicine & Dentistry of New Jersey / Univ Hosp
-
-
New York
-
Bronx、New York、美国、10457
- Bronx Lebanon Hosp Ctr
-
New York、New York、美国、10016
- Bellevue Hosp / New York Univ Med Ctr
-
New York、New York、美国、10032
- Columbia Presbyterian Med Ctr
-
New York、New York、美国、10032
- Incarnation Children's Ctr / Columbia Presbyterian Med Ctr
-
New York、New York、美国、10029
- Mount Sinai Med Ctr / Pediatrics
-
Rochester、New York、美国、14642
- Univ of Rochester Medical Center
-
Syracuse、New York、美国、13210
- SUNY Health Sciences Ctr at Syracuse / Pediatrics
-
-
North Carolina
-
Durham、North Carolina、美国、277103499
- Duke Univ Med Ctr
-
-
Ohio
-
Columbus、Ohio、美国、432052696
- Columbus Children's Hosp
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria
Prior Medication: Required:
- At least 6 months of prior AZT, including continuously during the current pregnancy.
Patients must have:
- HIV seropositivity.
- CD4 count <= 300 cells/mm3.
- Gestational age of 20-36 weeks, with intention to carry pregnancy to term.
- At least 6 months of prior AZT therapy, including continuous AZT therapy during the current pregnancy.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
- Evidence of pre-existing fetal anomalies that would preclude survival to the end of the study, such as anencephaly, renal agenesis, or Potter's syndrome.
Concurrent Medication:
Excluded:
- Antiretrovirals other than AZT.
学习计划
研究是如何设计的?
合作者和调查者
调查人员
- 学习椅:Bardeguez AD
- 学习椅:Pitt J
出版物和有用的链接
一般刊物
- Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999 Aug 5;341(6):394-402. doi: 10.1056/NEJM199908053410602.
- Bardeguez AD. Management of HIV infection for the childbearing age woman. Clin Obstet Gynecol. 1996 Jun;39(2):344-60. doi: 10.1097/00003081-199606000-00009. No abstract available.
- Bardeguez AD, Taylor U, Appuzio J, Leus C, Lister M, Denny T, Palumbo P, Connor E. Characteristics of pregnant women infected with human immunodeficiency virus 1: Newark perinatal transmission study. Int Conf AIDS. 1991 Jun 16-21;7(2):193 (abstract no WB2044)
- Welles SL, Pitt J, Colgrove R, McIntosh K, Chung PH, Colson A, Lockman S, Fowler MG, Hanson C, Landesman S, Moye J, Rich KC, Zorrilla C, Japour AJ. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group. AIDS. 2000 Feb 18;14(3):263-71. doi: 10.1097/00002030-200002180-00008.
研究记录日期
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.